胸腺肽α1,thymosin α1
1)thymosin α1胸腺肽α1
1.Effect of thymosin α1 on immune function and cytokines in patients with abdominal sepsis;胸腺肽α1对严重外科感染病人免疫功能和细胞因子的影响
2.Effect of thymosin α1 for advanced non-small-cell lung cancer in chemotherapy patients;胸腺肽α1在非小细胞肺癌治疗中的应用
3.Prevention of Ventilator-associated Pneumonia in the Patient with Longer Mechanical Ventilation Using Thymosin α1 (Zadaxin);胸腺肽α1在长期机械通气患者预防呼吸机相关肺炎的应用
英文短句/例句

1.The Pharmacology Comparison of PEG Thymosin α1 and Thymosin α1;聚乙二醇胸腺肽α1胸腺肽α1的药理学比较观察
2.Exploratory development of thymosin alpha 1 for nasopharyngeal carcinoma therapy胸腺肽α1在鼻咽癌治疗中的应用研究
3.Establishment of Prokaryotic Expression System of Canine IFNα1-THYα1 Fusion Protein;犬干扰素α1与胸腺肽α1融合蛋白原核表达系统的建立
4.The effect of thymosin alpha 1 on expression of signal transduction molecules in lymphocytes胸腺肽α1对淋巴细胞信号转导分子表达影响的研究
5.Expression, Seperation and Purification of Recombinant Human Thymosin α1 in E.coli;重组人胸腺肽α1在大肠杆菌中的表达与分离纯化
6.Recombinant Fusion Protein of Human IFNα_(2a) and Thyα1 Expressed in E.coli;重组人干扰素α_(2a)和胸腺肽α1融合蛋白在大肠杆菌中的表达
7.Study of Thymosin Peptide Alpha 1 on the T Lymphocyte Subsets of Patients with Hepatoceullar Carcinoma after TACE;胸腺肽α1对原发性肝癌TACE治疗后T淋巴细胞亚群影响
8.Study on Construction and Expression of Common IFN and THY α1 Fusion Gene;通用干扰素与胸腺肽α1融合基因构建与表达研究
9.Clone and Expression of Fusion Gene of THYα1-IFNα2b and Activity Analysis of Fusion Protein;胸腺肽α1-干扰素α2b融合基因克隆表达及产物活性分析
10.Study of Antitumor Immunotherapy Effect of Thymosin Alpha1 on DCs or DC Vaccines in Vivo and in Vitro;胸腺肽α1作用于树突状细胞的抗肿瘤免疫机制的实验研究
11.Establishment of Prokaryotic Expression System of Feline IFNω3-THYα1 Fusion Protein猫干扰素ω3与胸腺肽α1融合蛋白原核表达系统的建立
12.Study on Immunity Pharmacodynamics and Correlation Mechanism of Recombinant Human Thymosin Alpha-1 by Injection注射用重组人胸腺肽α1免疫药效学及相关机制的研究
13.An Experimental Study on the Effect of Tumor Specific CTL Combined with Thymosin α1 against Tumor in Vivo肿瘤特异性CTL联合胸腺肽α1体内肿瘤杀伤效应的实验研究
14.Pharmacokinetics of rh-Tα1 for injection in monkeys by enzyme-linked immunosorbent assay酶联免疫法研究注射用重组人胸腺肽α1的猕猴药动学
15.Effect of Lamivudine Combined with Thymic Peptide-α1 on Hepatitis B拉米夫定联合胸腺肽α1治疗慢性乙型肝炎的疗效观察
16.Effect of Alpha-1-thymosin on T-lymphocyte Subpopulations in Hepatocellular Carcinoma Patients before and after Transcatheter Arterial Chemoemb胸腺肽α1对原发性肝癌TACE术前术后T淋巴细胞亚群的影响
17.Effects of early application of thymosin peptide alpha 1 on T lymphocyte subsets after hepatectomy in patients with hepatocellular carcinoma肝癌术后早期应用胸腺肽α1对T淋巴细胞亚群的影响(英文)
18.Efficacy of combination with thymosin alpha 1 in older nosocomial infection patients联合应用胸腺肽α1治疗老年患者医院获得性肺感染的疗效观察
相关短句/例句

thymosinα1胸腺肽α1
1.Efficiency of thymosinα1 combined with Kushensu on treating chronic hepatitis B with iamivudine resistance.;胸腺肽α1联合苦参素胶囊治疗拉米夫定耐药的慢性乙型肝炎疗效观察
2.AIM:To prepare and evaluate the in vitro release characteristics of thymosinα1 tablet(Tα1 tablet).目的:制备胸腺肽α1结肠释放片(Tα1片),评价其体外释药性能。
3.The absorption of thymosinα1 in rat colon and enhancement effect of different absorption enhancers or protease inhibitor (sodium desoxycholate, Carbomer 940, water-soluble chitosan and bacitracin) were investigated using in situ perfusion method.考察了大鼠在体结肠对胸腺肽α1(1)及其在各吸收促进剂或酶抑制剂(去氧胆酸钠、卡波姆940、水溶性壳聚糖和杆菌肽)作用下的吸收情况。
3)thymosin alpha 1胸腺肽α1
1.OBJECTIVE To investigate the effects of thymosin alpha 1 on monocyte human leukocyte antigen DR(HLA-DR) and other immune parameters and the clinical significance in patients with acute cerebral infarction(ACI) and severe hospital acquired pneumonia(SHAP).目的:探讨胸腺肽α1治疗对脑梗死并发重症医院获得性肺炎(SHAP)患者单核细胞人类白细胞抗原DR(HLA-DR)等免疫指标的影响及其临床意义。
2.Objective To produce monoclonal antibody (McAb) against thymosin alpha 1 and make a foundation for the research and identification of thymosin alpha 1.目的 研制胸腺肽α1(Tα1)单克隆抗体 ,为Tα1作用机制的阐明奠定基础。
4)Thymosin α_1胸腺肽α1
1.Objective:To observe the effect of combined application Lamivudine and Thymosin α_1 in treating patients with chronic hepatitis B(CHB).目的:观察拉米夫定联合胸腺肽α1治疗慢性乙型肝炎(CHB)的疗效。
2.Purpose To study THP-1 cell line reactivity to endotoxin stimulation and the expression of Toll-like receptor 4(TLR4) after thymosin α_1 and granulocyte colony-stimulating factor(G-CSF) stimulation.目的观察粒细胞集落刺激因子(G-CSF)及胸腺肽α1刺激后,人单核细胞株(THP-1)对内毒素刺激的反应及对Toll样受体4mRNA表达的影响。
3.Objective: To compare the protective effects of polyethylene glycol thymosin α_1(PEG Tα_1) and thymosin(Tα_1)on immunological liver injury(ILI) in rats and to study the amelioration of pharmacodynamic action of Tα_1 after polyethylene glycol(PEG) modification.目的:比较聚乙二醇胸腺肽α1(PEG Tα1)和胸腺肽α1(Tα1)对免疫肝损伤大鼠的保护作用,观察Tα1经PEG修饰后药效学特征是否改变。
5)thymosin alpha1胸腺肽α1
1.AIM:To investigate the effects of thymosin alpha1(Tα1) on the differentiation,maturation and function of tumor lysate-pulsed dendritic cells(LyDCs) in vitro,and to study the antitumor effects on tumor models of the nude mice bearing colon cancer in vivo.目的:观察胸腺肽α1(Tα1)对结肠癌细胞裂解物(TuLy)负载DC(LyDC)的表型和功能的影响,以及二者联合应用对裸鼠结肠癌的治疗作用。
2.OBJECTIVE To study the effect of thymosin alpha1 on immune function in aged chronic obstructive pulmonary disease(COPD) during acute period.目的:探讨胸腺肽α1对老年慢性阻塞性肺病(COPD)免疫功能的影响。
6)thymosin-α1胸腺肽-α1
1.Researches have found that thymosin-α1 (Tα1) played an important role in the course of immune responses, and it may regulate immune system through enhancing the T cell functions.研究发现胸腺肽-α1(Tα1)在机体免疫应答过程中起着重要的作用,并认为其可能是通过增强T淋巴细胞功能而调节免疫系统的。
延伸阅读

胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液药物名称:胸腺肽注射液英文名:Thymopetidum Injection别名:胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液、胸腺因子注射液、胸腺因子D注射液。性状:本品为无色或微黄色澄明液体。药理作用: 促使骨髓产生的干细胞转变为T细胞,从而增强细胞免疫功能。 从健康乳牛胸腺中提取制得的多肽类细胞免疫调节剂。可作用于T淋巴细胞分化的各个阶段,有调节和增强人体免疫功能的作用,可提高机体的防病抗病能力,缩短感染性疾病的治疗周期。用于原发或继发性免疫缺陷病或免疫功能失调引起的各种疾病、自身免疫性疾病以及病毒或细菌性感染和肿瘤的辅助治疗。适应症: 用于免疫缺陷病、恶性肿瘤及病毒性疾病。 用于治疗各种原发性或继发性T细胞缺陷病,某些自身免疫性疾病,各种细胞免疫功能低下的疾病及肿瘤的辅助治疗.用量用法: 肌注:每次2-10mg,每日或隔日1次。对于胸腺发育不全症患者应做替代治疗,每日1mg/kg,病情好转后改为维持量每周1mg/kg。 静脉滴注:一次20~80mg,溶于500ml,0.9%氯化钠注射液或5%葡萄糖注射液,一日1次或遵医嘱。注意事项:1.对于过敏体质者,注射前或治疗终止后再用药时需做皮内敏感试验(配成25μg/ml的溶液,皮内注射0.1ml),阳性反应者禁用。2.本品如出现混浊或絮状沉淀物等异常变化,禁忌使用。3. 有发热、头晕、皮疹等。规格: 注射剂:2mg/2ml;5mg/2ml。2ml:5mg;2ml:20mg类别:免疫调节剂